1 David Ralph et al “MED3000, a clinically proven, fast-acting topical product for Erectile Dysfunction with the prospect of being the first globally available OTC treatment for ED” (MED3000 is the codename used when EROXON® was in the research stage).
2 FM57 Clinical Investigation Report dated 6th April 2020 FM71; Clinical Investigation Report dated 14 September 2022